Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022
Wed, May 11, 2022

Nathan Rich Maintained (AMRX) at Strong Buy with Decreased Target to $4.5 on, May 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-4-5-on-may-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Nathan Rich of Goldman Sachs, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Decreased Target from $6 to $4.5 on, May 12th, 2022.

Nathan, nor any peers, have made any analyst calls on AMRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources